Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer

NCT00945191 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer Stage IIIC
Ovarian Cancer Stage IV

Interventions

DRUG: CS-1008
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Daiichi Sankyo